Individuals were enrolled into five dose-escalating cohorts of three to six individuals each
Individuals were enrolled into five dose-escalating cohorts of three to six individuals each. Administration (FDA) for use in combination with doxorubicin for the treatment of adult individuals with STSs. In November 2016, the European Medicines Agency (EMA) granted conditional authorization for olaratumab in the same indicator under its Accelerated Assessment System. A double-blind, placebo-controlled, randomized…